LifeTech Scientific Corporation (1302.HK)
HKSE · HKD · Healthcare · Medical Devices
HK$1.54 (-3.14%) as of
Key statistics
- Market cap
- 6.78B
- P/E (TTM)
- 154.00
- EPS (TTM)
- 0.010
- Dividend yield
- 0.00%
- 52-week range
- 1.255 – 2.380
- Beta
- 0.31
- Revenue (TTM)
- 1.29B
- Profit margin
- 4.51%
- Volume
- 18.99M
About LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Shenzhen, China
- Employees
- 1,254
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.